No registrations found.
ID
Source
Brief title
Health condition
Type 2 diabetes
Sponsors and support
Intervention
Outcome measures
Primary outcome
HbA1c.
Secondary outcome
1. Lipid profile;
2. 6 point glucose profile;
3. Hypoglycemia;
4. Body weight;
5. Free fatty acids;
6. CRP.
Background summary
Diabetes is a disease characterized by abnormalities in both lipid and glucose metabolism. In a placebo controlled study reported by Khan, 15 to 25% reductions in fasting glucose, total and LDL cholesterol and triglycerides were seen after 40 days of treatment. While these results are very promising, a trial with longer duration and a widely accepted measure of overall glucose homeostasis, i.e. HbA1c, is needed.
Study objective
The main objective of this randomized, placebo-controlled trial is to determine the effects of cinnamon extract on HbA1c and lipid profiles in type 2 diabetic patients.
Study design
N/A
Intervention
Diabecinn tid or placebo.
P.O. Box 22660
J.H. DeVries
Meibergdreef 9
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5669111
j.h.devries@amc.uva.nl
P.O. Box 22660
J.H. DeVries
Meibergdreef 9
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5669111
j.h.devries@amc.uva.nl
Inclusion criteria
1. Type 2 diabetes patients;
2. Age 35-70 years inclusive;
3. HbA1c between 7 and 12% inclusive.
Exclusion criteria
1. Pregnancy;
2. Breast-feeding.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL579 |
| NTR-old | NTR635 |
| Other | : N/A |
| ISRCTN | ISRCTN36704940 |